Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Transitional Cell"" wg kryterium: Temat


Tytuł:
The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy.
Autorzy:
Huang LH; Department of Urology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.; Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan.
Chen CS; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Li JR; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Chiu KY; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Wang SS; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Yang CK; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Cheng CL; Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Lin CC; Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan. .; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. .; The iEGG and Animal Biotechnology Center, Advanced Plant and Food Crop Biotechnology Center, National Chung-Hsing University, Taichung, Taiwan. .; Department of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. .
Ou YC; Department of Urology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan. .; Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan. .; Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 22; Vol. 24 (1), pp. 247. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Urologic Neoplasms*/surgery
Urologic Neoplasms*/pathology
Carcinoma, Squamous Cell*/surgery
Humans ; Nephroureterectomy ; Retrospective Studies ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Epithelial Cells/pathology
Czasopismo naukowe
Tytuł:
Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.
Autorzy:
Lee CU; Department of Urology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Gyeonggi-do, Republic of Korea.
Lee JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Lee HW; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Chung JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Song W; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Kang M; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeon HG; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Sung HH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 12; Vol. 14 (1), pp. 3497. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ureter*/surgery
Ureter*/pathology
Ureteral Neoplasms*
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Kidney Neoplasms*/pathology
Humans ; Nephroureterectomy ; Nephrectomy ; Disease Progression ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery
Czasopismo naukowe
Tytuł:
Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II.
Autorzy:
Tanabe K; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Nakanishi Y; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan. .
Okubo N; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Matsumoto S; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Umino Y; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Kataoka M; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Yajima S; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Yoshida T; Department of Genetic Medicine, National Cancer Center Hospital, Tokyo, Japan.
Miyazaki S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.
Kuwata T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.; Department of Genetic Medicine, National Cancer Center Hospital East, Chiba, Japan.
Ishii G; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.
Watanabe R; Department of Genetic Medicine, National Cancer Center Hospital, Tokyo, Japan.; Department of Pathology, St. Marianna University School of Medicine, Kanagawa, Japan.
Masuda H; Department of Urology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-Shi, Chiba, 277-8577, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 05; Vol. 23 (1), pp. 940. Date of Electronic Publication: 2023 Oct 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/epidemiology
Carcinoma, Transitional Cell*/genetics
Colorectal Neoplasms, Hereditary Nonpolyposis*/diagnosis
Colorectal Neoplasms, Hereditary Nonpolyposis*/epidemiology
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
Urinary Bladder Neoplasms*
Kidney Neoplasms*
Ureteral Neoplasms*/diagnosis
Ureteral Neoplasms*/epidemiology
Urinary Tract*/metabolism
Urinary Tract*/pathology
Humans ; Female ; Male ; Mismatch Repair Endonuclease PMS2/genetics ; Mismatch Repair Endonuclease PMS2/metabolism ; Retrospective Studies ; Prevalence ; MutS Homolog 2 Protein/genetics ; MutS Homolog 2 Protein/metabolism ; MutL Protein Homolog 1/genetics ; MutL Protein Homolog 1/metabolism ; DNA Mismatch Repair
Czasopismo naukowe
Tytuł:
Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis.
Autorzy:
Zhou H; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Pan Y; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Xu M; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Wang S; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Li Y; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Liu X; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Pokaż więcej
Źródło:
Urology journal [Urol J] 2023 Dec 26; Vol. 20 (6), pp. 369-378. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/drug therapy
Ureteral Neoplasms*/pathology
Humans ; Chemotherapy, Adjuvant ; Kidney/pathology ; Mitomycin/therapeutic use
Czasopismo naukowe
Tytuł:
Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center study.
Autorzy:
Guan H; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wang G; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wang W; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zhou Y; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Liu Z; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Hou X; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yan J; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Sun S; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Hu K; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. .
Zhao J; Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Jul 18; Vol. 18 (1), pp. 120. Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*
Ureteral Neoplasms*/radiotherapy
Ureteral Neoplasms*/surgery
Ureteral Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Aged ; Radiotherapy, Adjuvant ; Retrospective Studies ; Kidney/pathology ; Neoplasm Recurrence, Local/radiotherapy
Czasopismo naukowe
Tytuł:
Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes.
Autorzy:
Zhu PY; Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China. .
Wang L; Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
Li KP; Department of Urology, Affiliated Hospital of Lanzhou University Second Hospital, Lanzhou, 730030, China.
Yin S; Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
Chen XB; Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 May 29; Vol. 21 (1), pp. 163. Date of Electronic Publication: 2023 May 29.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Kidney Neoplasms*/surgery
Ureteral Neoplasms*/surgery
Laparoscopy*/methods
Carcinoma, Transitional Cell*/surgery
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Urinary Tract*/pathology
Humans ; Nephroureterectomy/methods ; Observational Studies as Topic
Czasopismo naukowe
Tytuł:
Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
Autorzy:
Liu J; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of the Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing, China.; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.; Beijing Hospital Continence Center, Beijing, China.
Wu P; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of the Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing, China.; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.; Beijing Hospital Continence Center, Beijing, China.
Lai S; Department of Urology, Peking University People's Hospital, 100044, Beijing, China.
Wang J; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of the Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing, China. .; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. .; Beijing Hospital Continence Center, Beijing, China. .
Hou H; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of the Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing, China. .; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. .; Beijing Hospital Continence Center, Beijing, China. .
Zhang Y; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of the Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing, China. .; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. .; Beijing Hospital Continence Center, Beijing, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jun 22; Vol. 23 (1), pp. 574. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urologic Neoplasms*/pathology
Urinary Bladder Neoplasms*/pathology
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/pathology
Urinary Tract*/pathology
Humans ; Nephroureterectomy ; Prognosis ; Retrospective Studies ; Inflammation/pathology ; Machine Learning
Czasopismo naukowe
Tytuł:
Kidney-sparing surgery for distal high-risk ureteral carcinoma: Clinical efficacy and preliminary experiences in 22 patients.
Autorzy:
Jiang Y; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Peng Y; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ding S; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zheng Y; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
He Y; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liu J; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 7835-7843. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Ureteral Neoplasms*/surgery
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Humans ; Prospective Studies ; Kidney/pathology ; Treatment Outcome ; Retrospective Studies ; Nephrectomy/methods
Czasopismo naukowe
Tytuł:
ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.
Autorzy:
Kobayashi G; Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.
Hayashi T; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Sentani K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ikeda K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Babasaki T; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Shigematsu Y; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Sekino Y; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Uraoka N; Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.
Teishima J; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Matsubara A; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hinata N; Department of Urology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Oue N; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2023; Vol. 90 (2), pp. 94-103. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/genetics
Carcinoma, Transitional Cell*/genetics
Carcinoma, Transitional Cell*/pathology
Kidney Neoplasms*/genetics
Ureteral Neoplasms*/genetics
Ureteral Neoplasms*/metabolism
Ureteral Neoplasms*/pathology
Humans ; Urothelium/metabolism ; Urothelium/pathology ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Annexins/genetics ; Annexins/metabolism
Czasopismo naukowe
Tytuł:
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study.
Autorzy:
Liedberg F; Department of Urology Skåne University Hospital, Malmö, Sweden.; Institution of Translational Medicine, Lund University, Malmö, Sweden.
Hagberg O; Institution of Translational Medicine, Lund University, Malmö, Sweden.
Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Public Health and Clinical Medicine, Northern Register Centre, Umeå University, Umeå, Sweden.
Aljabery F; Division of Urology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Gårdmark T; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
Hosseini A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jahnson S; Division of Urology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Jerlström T; Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Ströck V; Department of Urology, Sahlgrenska University Hospital and Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Söderkvist K; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Ullén A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden.
Holmberg L; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Bobjer J; Department of Urology Skåne University Hospital, Malmö, Sweden.; Institution of Translational Medicine, Lund University, Malmö, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 02; Vol. 18 (2), pp. e0281304. Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/complications
Carcinoma, Transitional Cell*/pathology
Ureter*/pathology
Ureteral Neoplasms*/diagnosis
Ureteral Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Humans ; Nephrectomy/adverse effects ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery
Czasopismo naukowe
Tytuł:
A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence.
Autorzy:
Shimura S; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Matsumoto K; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Ikeda M; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Moroo S; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Koguchi D; Department of Urology, Kitasato University Medical Center, Kitamoto, Japan.
Taoka Y; Department of Urology, Kitasato University Medical Center, Kitamoto, Japan.
Hirayama T; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Murakami Y; Department of Urology, Kanagawa Prefectural Federation of Agricultural Cooperatives for Health and Welfare Sagamihara Kyodo Hospital, Sagamihara, Japan.
Utsunomiya T; Department of Urology, Kanagawa Prefectural Federation of Agricultural Cooperatives for Health and Welfare Sagamihara Kyodo Hospital, Sagamihara, Japan.
Matsuda D; Department of Urology, Higashiyamato Hospital, Higashiyamato, Japan.
Okuno N; Department of Urology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan.
Irie A; Department of Urology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Iwamura M; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Feb; Vol. 19 (1), pp. 71-78. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/pathology
Laparoscopy*/adverse effects
Ureteral Neoplasms*/etiology
Ureteral Neoplasms*/pathology
Ureteral Neoplasms*/surgery
Humans ; Nephroureterectomy ; Retrospective Studies ; Nephrectomy/adverse effects ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/surgery ; Neoplasm Recurrence, Local/etiology
Czasopismo naukowe
Tytuł:
Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on "Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019".
Autorzy:
Brehmer M; Department of Urology, Södersjukhuset and Department of Clinical Sciences, Karolinska Institutet KIDS, Stockholm, Sweden.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 Feb-Dec; Vol. 57 (1-6), pp. 22-23. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Editorial
MeSH Terms:
Urinary Bladder Neoplasms*
Carcinoma, Transitional Cell*
Ureteral Neoplasms*
Humans ; Incidence ; Scandinavian and Nordic Countries
Opinia redakcyjna
Tytuł:
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
Autorzy:
Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Grossman NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
Potretzke AM; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
Ghoreifi A; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Daneshmand S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Djaladat H; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Sfakianos JP; Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York City, New York, USA.
Mari A; Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Khene ZE; Department of Urology, Hospital Pontchaillou, CHU Rennes, Rennes, France.
D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Hayakawa N; Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan.
Breda A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.
Fontana M; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.
Fujita K; Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
Antonelli A; Urology Unit AUOI Verona, Department of Surgery, Dentistry, Pediatrics and Gynecology, University of Verona, Verona, Italy.
van Doeveren T; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Steinbach C; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Rouprêt M; GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France.
Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Quebec, Canada.
Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Compérat E; GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France.; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.; Department of Urology, Weill Cornell Medical College, New York City, New York, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Jan; Vol. 30 (1), pp. 63-69. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Ureteral Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Humans ; Nephroureterectomy ; Prognosis ; Ureteroscopy ; Biopsy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Ureteral tumor with morphological features analogous to phyllodes tumor: a unique case with concomitant urothelial carcinoma.
Autorzy:
Zhou W; Department of Stomatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Dang L; Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
Chong C; Department of Pathology, The Second People's Hospital of Heze, Heze, China.
Cheng X; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Huaiyin District, 250021, Jinan, Shandong, China.
Qin Y; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Huaiyin District, 250021, Jinan, Shandong, China.
Su W; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Huaiyin District, 250021, Jinan, Shandong, China. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Dec 23; Vol. 17 (1), pp. 94. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Ureteral Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Phyllodes Tumor*/surgery
Phyllodes Tumor*/complications
Breast Neoplasms*
Male ; Humans ; Aged
Czasopismo naukowe
Tytuł:
The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
Autorzy:
Hsieh HC; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Wang CL; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Family Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chen CS; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Yang CK; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Li JR; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Medicine and Nursing, Hungkuang University, Taichung, Taiwan.
Wang SS; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Medicine and Nursing, Hungkuang University, Taichung, Taiwan.
Cheng CL; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Lin CY; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chiu KY; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Dec 01; Vol. 17 (12), pp. e0278038. Date of Electronic Publication: 2022 Dec 01 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*
Ureteral Neoplasms*/surgery
Kidney Neoplasms*
Urinary Tract*
Humans ; Nephroureterectomy ; Prognosis ; Retrospective Studies ; Lymph Node Excision
Czasopismo naukowe
Tytuł:
S-phase - an independent prognostic marker in upper tract urothelial carcinoma.
Autorzy:
Malm C; Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden.; Stockholm South General Hospital, Stockholm, Sweden.
Jaremko G; Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden.
Brehmer M; Department of Clinical Sciences, Danderyd Hospital-Karolinska Institute, Stockholm, Sweden.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2022 Oct-Dec; Vol. 56 (5-6), pp. 397-403. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Ureteral Neoplasms*/pathology
Humans ; Prognosis ; Retrospective Studies ; Nephroureterectomy
Czasopismo naukowe
Tytuł:
Fibre optic ureteroscopes for the management of upper tract urothelial carcinoma? No thanks! Re: Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry.
Autorzy:
Ventimiglia E; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
Villa L; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
Salonia A; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
Traxer O; GRC n°20, Groupe de Recherche Clinique sur la Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France.; Service d'Urologie, Assistance-Publique Hôpitaux de Paris, Hôpital Tenon, Sorbonne Université, Paris, France.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Sep; Vol. 130 (3), pp. 395-396. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Letter; Comment
MeSH Terms:
Carcinoma, Transitional Cell*/diagnostic imaging
Carcinoma, Transitional Cell*/pathology
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/pathology
Urinary Bladder Neoplasms*
Humans ; Registries ; Ureteroscopes ; Ureteroscopy/methods
Opinia redakcyjna
Tytuł:
Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
Autorzy:
Grahn A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
Eisfeldt J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
Malm C; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Stockholm South General Hospital, Stockholm, Sweden.
Foroughi Asl H; Genomic Medicine Center, Karolinska University Hospital, Stockholm, Sweden.; Clinical Genomics Facility, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Jaremko G; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Tham E; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Brehmer M; Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.; Division of Urology, Danderyd Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Jul; Vol. 130 (1), pp. 92-101. Date of Electronic Publication: 2021 Aug 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/genetics
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/genetics
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/pathology
Urinary Bladder Neoplasms*/genetics
Genomics/methods ; Humans ; Kidney/abnormalities ; Nephroureterectomy ; Prognosis ; Urogenital Abnormalities
SCR Disease Name:
Renal Adysplasia
Czasopismo naukowe
Tytuł:
Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
Autorzy:
He L; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Gastroenterology, Chongqing General Hospital, Chongqing, China.
Yang B; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Jian D; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Luo H; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Wang D; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Dai N; Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University (Army Medical University), Chongqing, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Jul 19; Vol. 2022, pp. 2147494. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*
Kidney Neoplasms*/genetics
Papillomavirus Infections*
Ureteral Neoplasms*
Urinary Bladder Neoplasms*/genetics
Cytidine Deaminase/genetics ; Humans ; Kidney Pelvis/pathology ; Minor Histocompatibility Antigens/genetics ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
Autorzy:
Miyai K; Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan. .; Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, 359-8513, Japan. .
Kawamura K; Department of Urology, National Defense Medical College, Tokorozawa, Saitama, 359-8513, Japan.
Ito K; Department of Urology, National Defense Medical College, Tokorozawa, Saitama, 359-8513, Japan.
Matsukuma S; Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, 359-8513, Japan.
Tsuda H; Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jul 18; Vol. 22 (1), pp. 787. Date of Electronic Publication: 2022 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Kidney Neoplasms*/pathology
Kidney Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Ureteral Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Urinary Tract*/pathology
Humans ; Prognosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies